124 related articles for article (PubMed ID: 3299650)
1. [Treatment of advanced cancer of the ovary using intensive chemotherapy with autograft of bone marrow. From a case, discussion and review of the literature].
Nores JM; Dalayeun J; Otmezguine Y; Le Douarin LA; Folgoas C; Nenna A
Rev Fr Gynecol Obstet; 1987 May; 82(5):355-9. PubMed ID: 3299650
[TBL] [Abstract][Full Text] [Related]
2. [Cancer of the ovary treated by intensive chemotherapy and irradiation of the abdomen with bone marrow autograft: a case].
Nores JM; Dalayeun J; Otmezguine Y; Folgoas C; Nenna A
Ann Med Interne (Paris); 1988; 139(4):281-2. PubMed ID: 3056176
[No Abstract] [Full Text] [Related]
3. High-dose chemotherapy, total abdomen irradiation and autologous bone marrow infusion in ovarian cancer: an observation.
Norès JM; Dalayeun JF; Otmezguine Y; Folgoas C; Nenna AD
Gynecol Obstet Invest; 1989; 27(1):55-6. PubMed ID: 2646186
[TBL] [Abstract][Full Text] [Related]
4. High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results.
Bertucci F; Viens P; Delpero JR; Bardou VJ; Faucher C; Houvenaeghel G; Maraninchi D
Bone Marrow Transplant; 2000 Jul; 26(1):61-7. PubMed ID: 10918406
[TBL] [Abstract][Full Text] [Related]
5. Therapy of advanced ovarian juvenile granulosa cell tumors.
Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Harms D; Göbel U
Klin Padiatr; 2002; 214(4):173-8. PubMed ID: 12165898
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
Petit T; Velten M; d'Hombres A; Marchal C; Montbarbon X; Mornex F; Quetin P; Gérard JP; Romestaing P; Carrie C
Gynecol Oncol; 2007 Jan; 104(1):104-8. PubMed ID: 16987544
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of mono- and polychemotherapy in patients with advanced ovarian cancer].
Khasanova DT; Kotova DG
Vopr Onkol; 1984; 30(3):67-71. PubMed ID: 6369776
[TBL] [Abstract][Full Text] [Related]
8. Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status.
Berek JS; Hacker NF; Lagasse LD; Poth T; Resnick B; Nieberg RK
Obstet Gynecol; 1984 Aug; 64(2):207-12. PubMed ID: 6539884
[TBL] [Abstract][Full Text] [Related]
9. [Advanced cancer of the ovary. Treatment and results].
Wolff JP; George M; Duvillard P; Michel G; Pejovic MH; Haie C
J Gynecol Obstet Biol Reprod (Paris); 1986; 15(2):231-7. PubMed ID: 3722750
[TBL] [Abstract][Full Text] [Related]
10. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]
11. Advances in the management of epithelial ovarian cancer.
Berkenblit A; Cannistra SA
J Reprod Med; 2005 Jun; 50(6):426-38. PubMed ID: 16050567
[TBL] [Abstract][Full Text] [Related]
12. [A case of ovarian cancer stage IV and advanced rectal cancer responding to paclitaxel/carboplatin].
Kawaguchi R; Furukawa N; Morimoto Y; Ohi M; Osawa T; Koike H; Miyake T
Gan To Kagaku Ryoho; 2004 Apr; 31(4):619-22. PubMed ID: 15114712
[TBL] [Abstract][Full Text] [Related]
13. [Epithelial tumors of the ovary. Therapeutic results apropos of 165 cases of stage II and III tumors].
Dubois JB; Joyeux H; Solassol C; Pourquier H; Pujol H
J Gynecol Obstet Biol Reprod (Paris); 1985; 14(5):627-32. PubMed ID: 4067218
[TBL] [Abstract][Full Text] [Related]
14. Intensive sequential dose dense chemotherapy with stem cell support as first-line treatment in advanced ovarian carcinoma: a phase II study.
Viret F; Bertucci F; Genre D; Gravis G; Chabannon C; Conte M; Houvenaeghel G; Maraninchi D; Viens P
Bone Marrow Transplant; 2002 Dec; 30(12):879-84. PubMed ID: 12476280
[TBL] [Abstract][Full Text] [Related]
15. [Adjuvant treatment of cystadenocarcinoma].
Héron JF
Rev Prat; 1989 Nov; 39(26):2325-8. PubMed ID: 2595223
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors and better survival rate after the treatment of advanced ovarian cancer with neoadjuvant chemotherapy].
Ivanov S; Ivanov S; Khadzhiolov N
Akush Ginekol (Sofiia); 2004; 43(6):17-9. PubMed ID: 15669647
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy for advanced ovarian cancer.
Schwartz PE; Chambers JT; Makuch R
Gynecol Oncol; 1994 Apr; 53(1):33-7. PubMed ID: 8175019
[TBL] [Abstract][Full Text] [Related]
18. Multimodal approach to the treatment of stage III ovarian carcinoma: preliminary report of a pilot study and critical review.
Paule B; Frydman R; Chasseray JM
Biomed Pharmacother; 1985; 39(5):241-5. PubMed ID: 4084658
[TBL] [Abstract][Full Text] [Related]
19. [A stage IIIc ovarian cancer case of pathological CR after combination treatment with carboplatin and cisplatin].
Onishi Y; Maruyama H; Kume K; Hatae M
Gan To Kagaku Ryoho; 1994 Sep; 21(12):2053-6. PubMed ID: 8085858
[TBL] [Abstract][Full Text] [Related]
20. High-dose chemotherapy and hematopoietic progenitor cell support for patients with epithelial ovarian cancer.
Kotz KW; Schilder RJ
Semin Oncol; 1995 Jun; 22(3):250-62. PubMed ID: 7777869
[No Abstract] [Full Text] [Related]
[Next] [New Search]
